Displaying 1021 - 1040 of 2361
Watson Pharmaceuticals / Actavis Inc., In the Matter of
The FTC required Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive. The settlement protects competition in the markets for 21 current and future generic drugs, used to treat a wide range of conditions ranging from hypertension and diabetes to anxiety and attention deficit hyperactivity disorder (ADHD).
There is a related federal proceeding and two related administrative proceedings:
Administrative Law Judge Upholds FTC’s Complaint Allegations that Merger of Major Titanium Dioxide Companies would have Harmed Competition
FTC Testifies before House Subcommittee on Regulatory Reform, Commercial and Antitrust Law on Competition Enforcement Activities and Policy Priorities
FTC Tops the List of “Best Places to Work” Among Mid-Size Federal Agencies
FTC Charges Executive Whose Company Owns New York Knicks, New York Rangers with Violations of U.S. Premerger Notification Requirements
FTC Submits Comment on FDA Guidance Aimed at Deterring Abuse of Citizen Petition Process
FTC Approves Modified Final Order Imposing Conditions on Northrop Grumman’s Acquisition of Solid Rocket Motor Supplier Orbital ATK, Inc.
FTC Hearings on Competition and Consumer Protection in the 21st Century Continue With Examination of Acquisitions Involving Ownership Interests in Competing Companies
Northrop Grumman and Orbital ATK, In the Matter of
Statement of Federal Trade Commission Concerning Its Vote to Close the Investigation of a Proposed Transaction Combining Massachusetts Healthcare Providers
FTC Requests Public Comment on Supervalu Inc.’s Application to Approve Sale of 2 Supermarkets Operating under the Shop ’n Save Banner in Va. and W. Va.
FTC Issues Annual Report on Ethanol Market Concentration 2018
FTC Requests Public Comment on an Application from Praxair and Linde to Approve Sale of an Industrial Gases Plant to Celanese Ltd.
FTC Announces Agenda for the Eighth Session of its Hearings on Competition and Consumer Protection in the 21st Century; Session at New York University to Focus on “Common Ownership”
FTC Hearing #8: Common Ownership
FTC Commissioners Find that 1-800 Contacts Unlawfully Harmed Competition in Online Search Advertising Auctions, Restricting the Availability of Truthful Advertising to Consumers
Displaying 1021 - 1040 of 2361